Niagen Bioscience management to present at Longevity Investors Conference
Niagen Bioscience, Inc. (NAGE) said senior management will participate in the Longevity Investors Conference from September 14 to 17, 2026, in Gstaad.
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces that senior management will participate at the Longevity Investors Conference, taking place from September 14 to 17, 2026, in Gstaad…